Literature DB >> 12637586

Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.

Jung Hwan Hwang1, Dong Wook Kim, Jae Mi Suh, Ho Kim, Jung Hun Song, Eun Suk Hwang, Ki Cheol Park, Hyo Kyun Chung, Jin Man Kim, Tae-Hoon Lee, Dae-Yeul Yu, Minho Shong.   

Abstract

Thyroid papillary carcinomas are characterized by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) rearrangements that result in fusion of the tyrosine kinase domain of the RET receptor to the N-terminal sequences encoded by heterologous genes. This thyroid-specific rearrangement causes aberrant expression of RET/PTC and results in constitutive ligand-independent activation of RET kinase. However, it is unclear how RET/PTC activates the specific signaling pathways for cellular transformation. In this study, we show that RET/PTC associates with signal transducer and activator of transcription 3 (STAT3) and activates it by the specific phosphorylation of the tyrosine 705 residue. Activation of STAT3 requires the intrinsic kinase activity of RET/PTC; Janus tyrosine kinase and c-Src kinase are not involved in the RET/PTC-mediated activation of STAT3. RET/PTC-induced activation of STAT3 induces the STAT3-responsive genes, vascular endothelial growth factor, cyclin D1, and intercellular adhesion molecule 1. In addition, RET/PTC-mediated cellular transformation and proliferation of transformed cells require tyrosine 705 phosphorylation of STAT3 in NIH3T3 cells. We conclude that STAT3 activation by the RET/PTC tyrosine kinase is one of the critical signaling pathways for the regulation of specific genes, such as cyclin D1, vascular endothelial growth factor, and intercellular adhesion molecule 1, and for cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637586     DOI: 10.1210/me.2002-0401

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  20 in total

1.  Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.

Authors:  Sun Mi Hong; Chang Wook Park; Hyung Jin Cha; Jung Hee Kwon; Young Sung Yun; Nam Gyu Lee; Dae-Ghon Kim; Hong Gil Nam; Kwan Yong Choi
Journal:  Clin Exp Metastasis       Date:  2012-08-09       Impact factor: 5.150

2.  Aberrant sonic hedgehog signaling pathway and STAT3 activation in papillary thyroid cancer.

Authors:  Wenwu Dong; Junshuai Cui; Xinshuai Tian; Liang He; Zhihong Wang; Ping Zhang; Hao Zhang
Journal:  Int J Clin Exp Med       Date:  2014-07-15

3.  Down-regulation of microRNA-21 is involved in the propofol-induced neurotoxicity observed in human stem cell-derived neurons.

Authors:  Danielle M Twaroski; Yasheng Yan; Jessica M Olson; Zeljko J Bosnjak; Xiaowen Bai
Journal:  Anesthesiology       Date:  2014-10       Impact factor: 7.892

4.  Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer.

Authors:  Jingdong Zhang; Anthony Gill; Bryn Atmore; Amber Johns; Leigh Delbridge; Raymond Lai; Todd McMullen
Journal:  Int J Clin Exp Pathol       Date:  2011-04-28

5.  STAT3 negatively regulates thyroid tumorigenesis.

Authors:  Joana Pinto Couto; Laura Daly; Ana Almeida; Jeffrey A Knauf; James A Fagin; Manuel Sobrinho-Simões; Jorge Lima; Valdemar Máximo; Paula Soares; David Lyden; Jacqueline F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

6.  Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer.

Authors:  Daphne R Pringle; Zhirong Yin; Audrey A Lee; Parmeet K Manchanda; Lianbo Yu; Alfred F Parlow; David Jarjoura; Krista M D La Perle; Lawrence S Kirschner
Journal:  Endocr Relat Cancer       Date:  2012-05-24       Impact factor: 5.678

7.  OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma.

Authors:  Wenli Liu; Hongzhen Li; Wulin Aerbajinai; Istvan Botos; Griffin P Rodgers
Journal:  Oncogene       Date:  2021-10-21       Impact factor: 9.867

8.  Role of STAT3 in in vitro transformation triggered by TRK oncogenes.

Authors:  Claudia Miranda; Tiziana Fumagalli; Maria Chiara Anania; Maria Grazia Vizioli; Sonia Pagliardini; Marco A Pierotti; Angela Greco
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

9.  AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.

Authors:  Joana P Couto; Ana Almeida; Laura Daly; Manuel Sobrinho-Simões; Jacqueline F Bromberg; Paula Soares
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

10.  Linear combinations of docking affinities explain quantitative differences in RTK signaling.

Authors:  Andrew Gordus; Jordan A Krall; Elsa M Beyer; Alexis Kaushansky; Alejandro Wolf-Yadlin; Mark Sevecka; Bryan H Chang; John Rush; Gavin MacBeath
Journal:  Mol Syst Biol       Date:  2009-01-20       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.